ZAID AKRAM HAMMOODI
WALLINGFORD, CT
Browse related groups: CT Acerta Pharma LLC All categories
This page merges CMS profile IDs: 7231526, 8224804 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$616.19
- Category: General Payments
- Program years: PY2019–2024
- Record count: 14
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $190.46 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $190.46 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $117.37 | 1 |
| Retrophin, Inc. | $37.26 | 3 |
| Aurinia Pharma U.S., Inc. | $19.32 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.51 | 1 |
By program year
Records — PY2024 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086224294 | Bayer Healthcare Pharmaceuticals Inc. | $16.51 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104323882 | AstraZeneca Pharmaceuticals LP | $117.37 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149887661 | Travere Therapeutics, Inc. | $2.29 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149887665 | Travere Therapeutics, Inc. | $16.43 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149887669 | Travere Therapeutics, Inc. | $18.54 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150681519 | Aurinia Pharma U.S., Inc. | $19.32 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 7231526, 8224804
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.